Pouessel D - Search Results

1

Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with No Progression and with No More than Five Residual Metastatic Lesions Following First-Line Systemic Therapy: A Retrospective Analysis.

Aboudaram A, Chaltiel L, Pouessel D, Graff-Cailleaud P, Benziane-Ouaritini N, Sargos P, Schick U, Créhange G, Cohen-Jonathan Moyal E, Chevreau C, Khalifa J. Aboudaram A, et al. Among authors: pouessel d. Cancers (Basel). 2023 Feb 11;15(4):1161. doi: 10.3390/cancers15041161. Cancers (Basel). 2023. PMID: 36831503 Free PMC article.

2

[Renal cell carcinoma and antiangiogenic therapies].

Pouessel D, Culine S, Verhoest G, Patard JJ. Pouessel D, et al. Presse Med. 2008 Apr;37(4 Pt 2):628-33. doi: 10.1016/j.lpm.2007.07.007. Epub 2007 Nov 26. Presse Med. 2008. PMID: 18035517 Review. French.

3

Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy in bladder cancer: ready for prime time?

Pouessel D, Gauthier H, Serrate C, Pfister C, Culine S. Pouessel D, et al. J Clin Oncol. 2014 Dec 20;32(36):4168-9. doi: 10.1200/JCO.2014.58.0498. Epub 2014 Nov 10. J Clin Oncol. 2014. PMID: 25385728 No abstract available.

4

Gemcitabine and docetaxel after failure of cisplatin-based chemotherapy in patients with carcinoma of unknown primary site.

Pouessel D, Culine S, Becht C, Romieu G, Fabbro M, Ychou M, Cupissol D, Pinguet F. Pouessel D, et al. Anticancer Res. 2003 May-Jun;23(3C):2801-4. Anticancer Res. 2003. PMID: 12926116 Clinical Trial.

5

[Molecular biology of castration-resistant prostate cancer].

Doucet L, Terrisse S, Gauthier H, Pouessel D, Le Maignan C, Teixeira L, Culine S. Doucet L, et al. Among authors: pouessel d. Bull Cancer. 2015 Jun;102(6):497-500. doi: 10.1016/j.bulcan.2015.04.014. Epub 2015 May 28. Bull Cancer. 2015. PMID: 26028493 Review. French.

6

Phase II study of melphalan as a single-agent infused over a 24-hour period with individual adapted dosing in patients with recurrent epithelial ovarian cancer.

Mougenot P, Fabbro M, Bressolle F, Pouessel D, Culine S, Pinguet F. Mougenot P, et al. Among authors: pouessel d. Oncol Rep. 2006 Jan;15(1):237-41. Oncol Rep. 2006. PMID: 16328062 Clinical Trial.

7

[Towards the individualisation of prescriptions in oncology: urogenital cancers].

Pouessel D, Culine S. Pouessel D, et al. Bull Cancer. 2008 Oct;95(10):975-8. doi: 10.1684/bdc.2008.0731. Bull Cancer. 2008. PMID: 19004728 French.

8

Two cases of non-small-cell lung cancer with rare complex mutation of EGFR exon 18 but different response to targeted therapy.

Gauthier H, Douchet G, Lehmann-Che J, Meignin V, Raynaud C, Sabatier P, de Cremoux H, Poirot B, Culine S, Pouessel D, de Cremoux P. Gauthier H, et al. Among authors: pouessel d. J Thorac Oncol. 2014 Oct;9(10):e78-9. doi: 10.1097/JTO.0000000000000328. J Thorac Oncol. 2014. PMID: 25521408 Free article. No abstract available.

9

New therapies in renal cell carcinoma.

Patard JJ, Pouessel D, Culine S. Patard JJ, et al. Among authors: pouessel d. Curr Opin Support Palliat Care. 2007 Oct;1(3):174-9. doi: 10.1097/SPC.0b013e3282f1238b. Curr Opin Support Palliat Care. 2007. PMID: 18685359 Review.

10

Words of wisdom. Re: International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial.

Pouessel D, Culine S, Mongiat-Artus P. Pouessel D, et al. Eur Urol. 2011 Oct;60(4):870-1. doi: 10.1016/j.eururo.2011.07.032. Eur Urol. 2011. PMID: 21878198 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters